Skip to main content
OpenTrials

Clinical trial condition

Geographic Atrophy

Explore clinical trials studying Geographic Atrophy. Study availability and eligibility vary by location and protocol.

137 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Geographic Atrophy trial results

Completed

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

NCT01342926

Conditions
Atrophy, Geographic, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Arcadia, California, United States
  • GSK Investigational Site Irvine, California, United States
View all 41 locations
View Trial Details
Completed

A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy

NCT01229215

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Tucson, Arizona, United States
  • Beverly Hills, California, United States
  • San Francisco, California, United States
  • Santa Barbara, California, United States
View all 36 locations
View Trial Details
Completed

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

NCT01002950

Conditions
Dry Age-related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Covance Clinical Research Unit, Inc. Daytona Beach, Florida, United States
  • National Ophthalmic Research Institute Fort Meyers, Florida, United States
View Trial Details

Related conditions